The 3rd U.S. Circuit Court of Appeals has tossed out a Delaware pharmaceutical company's antitrust suit in which it claimed Pennsylvania and Tennessee drugmakers conspired to drive up the price of generic versions of brand-name muscle relaxant Skelaxin.
December 21, 2011 at 12:00 AM
1 minute read
The original version of this story was published on The Legal Intelligencer
The 3rd U.S. Circuit Court of Appeals has tossed out a Delaware pharmaceutical company’s antitrust suit in which it claimed Pennsylvania and Tennessee drugmakers conspired to drive up the price of generic versions of brand-name muscle relaxant Skelaxin.
The appeals court affirmed U.S. District Court for the Eastern District of Pennsylvania Judge Cynthia M. Rufe’s ruling, in which she had dismissed the suit for lack of standing.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
